Survival after Stevens‒Johnson Syndrome or Toxic Epidermal Necrolysis: A United Kingdom‒Based Cohort Study

Affiliations

• ¹ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.
• ² Insel Data Coordination Lab, Inselspital Bern, Bern, Switzerland.
• ³ Internal Medicine, Zuger Kantonsspital, Baar, Switzerland.
• ⁴ Allergology, University Hospital Basel, Basel, Switzerland.
• ⁵ Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA; Boston University, School of Public Health, Boston, Massachusetts, USA.
• ⁶ Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switzerland; Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA. Electronic address: christoph.meier@usb.ch.